Published in Cold Spring Harb Symp Quant Biol on January 01, 1998
TATA element recognition by the TATA box-binding protein has been conserved throughout evolution. Genes Dev (1999) 2.50
Trypanosome spliced leader RNA genes contain the first identified RNA polymerase II gene promoter in these organisms. Nucleic Acids Res (2001) 1.60
The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing. Nucleic Acids Res (2000) 1.50
Wnt activation and alternative promoter repression of LEF1 in colon cancer. Mol Cell Biol (2006) 1.48
Targeted transcriptional repression of Gfi1 by GFI1 and GFI1B in lymphoid cells. Nucleic Acids Res (2004) 1.34
Characterization of the human beta-globin downstream promoter region. Nucleic Acids Res (2003) 1.24
Widespread use of TATA elements in the core promoters for RNA polymerases III, II, and I in fission yeast. Mol Cell Biol (2001) 1.09
Core promoter-dependent TFIIB conformation and a role for TFIIB conformation in transcription start site selection. Mol Cell Biol (2002) 1.06
Peroxisomal monodehydroascorbate reductase. Genomic clone characterization and functional analysis under environmental stress conditions. Plant Physiol (2005) 1.02
Distinct transcriptional pathways regulate basal and activated major histocompatibility complex class I expression. Mol Cell Biol (2003) 0.99
Core promoter structure in the oomycete Phytophthora infestans. Eukaryot Cell (2004) 0.97
Transcription of the herpes simplex virus 1 genome during productive and quiescent infection of neuronal and nonneuronal cells. J Virol (2014) 0.96
Genetic analysis of the human papillomavirus type 31 differentiation-dependent late promoter. J Virol (2005) 0.95
Core promoter elements of eukaryotic genes have a highly distinctive mechanical property. Nucleic Acids Res (2004) 0.94
ATG deserts define a novel core promoter subclass. Genome Res (2005) 0.92
Initiator recognition in a primitive eukaryote: IBP39, an initiator-binding protein from Trichomonas vaginalis. Mol Cell Biol (2001) 0.90
The Epstein-Barr virus protein kinase BGLF4 and the exonuclease BGLF5 have opposite effects on the regulation of viral protein production. J Virol (2009) 0.89
Core promoters in transcription: old problem, new insights. Trends Biochem Sci (2015) 0.87
SRC proximal and core promoter elements dictate TAF1 dependence and transcriptional repression by histone deacetylase inhibitors. Mol Cell Biol (2004) 0.86
A highly distinctive mechanical property found in the majority of human promoters and its transcriptional relevance. Nucleic Acids Res (2005) 0.83
Major histocompatibility complex class I core promoter elements are not essential for transcription in vivo. Mol Cell Biol (2013) 0.79
Three enhancements to the inference of statistical protein-DNA potentials. Proteins (2012) 0.77
Transcriptional modulation of the pre-implantation embryo-specific Rnf35 gene by the Y-box protein NF-Y/CBF. Biochem J (2005) 0.77
The Sulfolobus initiator element is an important contributor to promoter strength. J Bacteriol (2013) 0.77
Terminal deoxynucleotidyl transferase is down-regulated by AP-1-like regulatory elements in human lymphoid cells. Immunology (2004) 0.75
An affinity-structure database of helix-turn-helix: DNA complexes with a universal coordinate system. BMC Bioinformatics (2015) 0.75
FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70
Kidney transplantation under FK 506. JAMA (1990) 7.45
Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90
Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med (2001) 4.01
DNA sequence requirements for transcriptional initiator activity in mammalian cells. Mol Cell Biol (1994) 3.76
Implementation of a high-sensitivity Micro-Angiographic Fluoroscope (HS-MAF) for in-vivo endovascular image guided interventions (EIGI) and region-of-interest computed tomography (ROI-CT). Proc SPIE Int Soc Opt Eng (2008) 3.49
Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29
The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14
The Xenopus Chk1 protein kinase mediates a caffeine-sensitive pathway of checkpoint control in cell-free extracts. J Cell Biol (1998) 3.13
Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation (1992) 2.75
Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot project. Arthritis Rheum (2009) 2.57
A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. Transplant Proc (1991) 2.49
Pharmacokinetics of FK 506: preclinical and clinical studies. Transplant Proc (1990) 2.48
Maternal feeding practices and beliefs and their relationships to overweight in early childhood. J Dev Behav Pediatr (2001) 2.39
The effects of FK 506 on renal function after liver transplantation. Transplant Proc (1990) 2.31
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. Transplant Proc (1991) 2.26
Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res (2001) 2.22
A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium. Gene Ther (2006) 2.21
Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J (2002) 2.19
Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology (1999) 2.15
Cardiovascular risk assessment of South Asians in a religious setting: a feasibility study. Int J Clin Pract (2011) 2.12
One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. Transplant Proc (1991) 2.10
Reduction in radiation exposure during coronary angiography. Cathet Cardiovasc Diagn (1990) 2.03
The lymphoid transcription factor LyF-1 is encoded by specific, alternatively spliced mRNAs derived from the Ikaros gene. Mol Cell Biol (1994) 1.99
Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet (1995) 1.96
BCL-6 expression during B-cell activation. Blood (1996) 1.95
Infections in adult liver transplant patients under FK 506 immunosuppression. Transplant Proc (1991) 1.75
Investigating the thyroid nodule. BMJ (2009) 1.73
The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. J Am Coll Surg (1996) 1.71
Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine. Transplant Proc (1991) 1.69
Mechanism of initiator-mediated transcription: evidence for a functional interaction between the TATA-binding protein and DNA in the absence of a specific recognition sequence. Mol Cell Biol (1993) 1.63
The question of FK 506 nephrotoxicity after liver transplantation. Transplant Proc (1991) 1.60
Accuracy and applicability of the revised WHO classification (2009) of dengue in children seen at a tertiary healthcare facility in northern India. Infection (2013) 1.59
Oral glucose tolerance test in liver recipients treated with FK 506. Transplant Proc (1990) 1.56
Ambiguous coronary angiography: clinical utility of intravascular ultrasound. Cathet Cardiovasc Diagn (1992) 1.54
Morphological effects of coronary balloon angioplasty in vivo assessed by intravascular ultrasound imaging. Circulation (1992) 1.53
Concurrent dengue virus and Japanese encephalitis virus infection of the brain: is it co-infection or co-detection? Infection (2012) 1.52
Polymerase chain reaction vs. conventional diagnosis in fine needle aspirates of tuberculous lymph nodes. Acta Cytol (2001) 1.51
An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis. Am J Transplant (2001) 1.48
Bacteriology of neonatal septicaemia in a tertiary care hospital of northern India. Indian J Med Microbiol (2007) 1.48
Converted laparoscopic colorectal surgery. Surg Endosc (2001) 1.48
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. Transplantation (1992) 1.45
Coronary artery fistula related to dilatation of totally occluded vessel. Clin Cardiol (1993) 1.44
Glutathione is required for intestinal function. Proc Natl Acad Sci U S A (1990) 1.43
Transversus abdominis plane block using the loss of resistance to air technique. Minerva Anestesiol (2012) 1.43
Inhibition of glutathione synthesis in the newborn rat: a model for endogenously produced oxidative stress. Proc Natl Acad Sci U S A (1991) 1.43
Radical radiotherapy and salvage cystectomy as the primary management of transitional cell carcinoma of the bladder. Results following the introduction of a CT planning technique. Clin Oncol (R Coll Radiol) (2002) 1.42
Adverse effects associated with the use of FK 506. Transplant Proc (1991) 1.41
Treatment of new pulmonary tuberculosis patients: what do allopathic doctors do in India? Int J Tuberc Lung Dis (2002) 1.40
Mandibular nerve block for peri-operative pain relief using a peripheral nerve stimulator. Anaesthesia (2012) 1.40
Hypokalaemia mimicking Guillain-Barre syndrome. J Assoc Physicians India (1989) 1.39
Administration of an alginate based gastric reflux suppressant on the bioavailability of omeprazole. Indian J Med Res (2006) 1.39
Induction of ventricular tachycardia in patients with left ventricular aneurysms and no history of arrhythmia. Am J Cardiol (1988) 1.39
Gallbladder carcinoma: experience of 116 cases. Trop Gastroenterol (2000) 1.39
Methotrexate for rheumatoid arthritis. J Assoc Physicians India (1994) 1.39
Thoracic epidural catheterization leading to delayed transient neurological symptoms with normal imaging findings. Acta Anaesthesiol Scand (2008) 1.38
Glutathione ester prevents buthionine sulfoximine-induced cataracts and lens epithelial cell damage. Proc Natl Acad Sci U S A (1989) 1.37
FK 506 conversion of renal allografts failing cyclosporine immunosuppression. Transplant Proc (1991) 1.37
Neurologic complications of FK 506. Transplant Proc (1991) 1.34
Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. Ann Surg (1994) 1.33
Pharmacokinetics and pharmacodynamics of GS-9350: a novel pharmacokinetic enhancer without anti-HIV activity. Clin Pharmacol Ther (2009) 1.32
Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM. Am J Physiol (1996) 1.30
Infections with FK 506 immunosuppression: preliminary results with primary therapy. Transplant Proc (1990) 1.30
De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl (2001) 1.30
Pharmacokinetics of FK 506 in transplant patients. Transplant Proc (1991) 1.30
RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy. Gene Ther (2006) 1.29
Prevalence of dental caries and treatment needs in the school-going children of rural areas in Udaipur district. J Indian Soc Pedod Prev Dent (2007) 1.29
Coronary artery fistula: an abnormality affecting all age groups. Medicine (Baltimore) (1990) 1.27
Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C. Am J Transplant (2006) 1.26
Cross-validation of a new procedure for early screening of smoking cessation medications in humans. Clin Pharmacol Ther (2010) 1.26
Development of satranidazole mucoadhesive gel for the treatment of periodontitis. AAPS PharmSciTech (2009) 1.25
An analysis of time utilization and cancellations of scheduled cases in the main operation theater complex of a tertiary care teaching institute of North India. J Postgrad Med (2014) 1.24
Down-regulation of TDT transcription in CD4(+)CD8(+) thymocytes by Ikaros proteins in direct competition with an Ets activator. Genes Dev (2001) 1.24
Dynactin regulates bidirectional transport of dense-core vesicles in the axon and dendrites of cultured hippocampal neurons. Neuroscience (2009) 1.23
An immunologically active arabinogalactan from Tinospora cordifolia. Phytochemistry (1999) 1.22
Immunopathological study of spleen during Japanese encephalitis virus infection in mice. Br J Exp Pathol (1988) 1.22
Mechanism of synergy between TATA and initiator: synergistic binding of TFIID following a putative TFIIA-induced isomerization. Genes Dev (1997) 1.21
Glutathione metabolism in the lung: inhibition of its synthesis leads to lamellar body and mitochondrial defects. Proc Natl Acad Sci U S A (1989) 1.21
Prevalence of gingival diseases, malocclusion and fluorosis in school-going children of rural areas in Udaipur district. J Indian Soc Pedod Prev Dent (2007) 1.21
The changing epidemiological pattern of hepatitis A in an urban population of India: emergence of a trend similar to the European countries. Eur J Epidemiol (2000) 1.18
Adverse effects of FK 506 overdosage after liver transplantation. Transplant Proc (1993) 1.18
Socioeconomic gradient in old age mortality in Wuhan, China. J Gerontol B Psychol Sci Soc Sci (2000) 1.17
Occurrence of overlooked zoonotic tuberculosis: detection of Mycobacterium bovis in human cerebrospinal fluid. J Clin Microbiol (2006) 1.17
Efficacy and safety of acarbose in metformin-treated patients with type 2 diabetes. Diabetes Care (1998) 1.16
Diagnostic evaluation of pulmonary tuberculosis: what do doctors of modern medicine do in India? Int J Tuberc Lung Dis (2003) 1.15
Fluphenazine dose, clinical response, and extrapyramidal symptoms during acute treatment. Arch Gen Psychiatry (1990) 1.14
Intramuscular haemangioma of head and neck region. J Laryngol Otol (1998) 1.14
A follow-up study of balloon angioplasty and de-novo stenting in Takayasu arteritis. Int J Cardiol (2000) 1.14
EMCCD-based high resolution dynamic x-ray detector for neurovascular interventions. Conf Proc IEEE Eng Med Biol Soc (2011) 1.14
A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients. Transplant Proc (1995) 1.13
Modification of the NEMA XR21-2000 cardiac phantom for testing of imaging systems used in endovascular image guided interventions. Proc SPIE Int Soc Opt Eng (2009) 1.11
Development of a new microparticle-enhanced turbidimetric assay for C-reactive protein with superior features in analytical sensitivity and dynamic range. J Clin Lab Anal (1998) 1.11
Postoperative analgesia with no motor block by continuous epidural infusion of ropivacaine 0.1% and sufentanil after total hip replacement. Anesth Analg (1999) 1.11
1H and 13C HR-MAS NMR investigations on native and enzymatically digested bovine nasal cartilage. MAGMA (2001) 1.10
Intention-based critiquing of guideline-oriented medical care. Proc AMIA Symp (1998) 1.10
Dose Reduction Technique Using a Combination of a Region of Interest (ROI) Material X-Ray Attenuator and Spatially Different Temporal Filtering for Fluoroscopic Interventions. Proc SPIE Int Soc Opt Eng (2012) 1.10
Intracavitary thrombi in the right heart associated with multiple pulmonary emboli. Report of two patients. Chest (1983) 1.10
Living-donor liver transplantation in the United States: identifying donors at risk for perioperative complications. Am J Transplant (2007) 1.10
Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast. Cancer Res (2001) 1.09